Follow
Jaroslav Zak
Jaroslav Zak
Verified email at scripps.edu
Title
Cited by
Cited by
Year
The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule
BCS Cross, PJ Bond, PG Sadowski, BK Jha, J Zak, JM Goodman, ...
Proceedings of the National Academy of Sciences, 2012
5712012
Chronic Obstructive Pulmonary Disease: Official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD …
V Koblizek, J Chlumsky, V Zindr, K Neumannova, J Zatloukal, J Zak, ...
Biomedical Papers, 2013
1902013
ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1
Y Wang, F Bu, C Royer, S Serres, JR Larkin, MS Soto, NR Sibson, ...
Nature cell biology 16 (11), 1092-1104, 2014
1582014
A Code for RanGDP Binding in Ankyrin Repeats Defines a Nuclear Import Pathway
M Lu, J Zak, S Chen, L Sanchez-Pulido, DT Severson, J Endicott, ...
Cell 157 (5), 1130-1145, 2014
802014
Heterozygous variants in KMT2E cause a spectrum of neurodevelopmental disorders and epilepsy
AH O’Donnell-Luria, LS Pais, V Faundes, JC Wood, A Sveden, V Luria, ...
The American Journal of Human Genetics 104 (6), 1210-1222, 2019
632019
Progression of type 1 diabetes from the prediabetic stage is controlled by interferon-α signaling
BS Marro, BC Ware, J Zak, JC de la Torre, H Rosen, MBA Oldstone
Proceedings of the National Academy of Sciences, 2017
592017
IL-27 promotes the expansion of self-renewing CD8+ T cells in persistent viral infection
Z Huang*, J Zak*, I Pratumchai*, N Shaabani, VF Vartabedian, N Nguyen, ...
Journal of Experimental Medicine 216 (8), 1791-1808, 2019
512019
ASPP2 Links the Apical Lateral Polarity Complex to the Regulation of YAP Activity in Epithelial Cells
C Royer, S Koch, X Qin, J Zak, L Buti, E Dudziec, S Zhong, I Ratnayaka, ...
PloS one 9 (10), e111384, 2014
442014
Establishing a Flow Process to Coumarin‐8‐Carbaldehydes as Important Synthetic Scaffolds
J Zak, D Ron, E Riva, HP Harding, B Cross, IR Baxendale
Chemistry-A European Journal 18 (32), 9901-9910, 2012
442012
Discovery of Small Molecules for the Reversal of T Cell Exhaustion
BS Marro*, J Zak*, RB Zavareh, JR Teijaro, LL Lairson, MBA Oldstone
Cell Reports 29 (10), 3293-3302. e3, 2019
402019
B cell–derived IL-27 promotes control of persistent LCMV infection
I Pratumchai, J Zak, Z Huang, B Min, MBA Oldstone, JR Teijaro
Proceedings of the National Academy of Sciences 119 (3), e2116741119, 2022
132022
IFNAR1 signaling in NK cells promotes persistent virus infection
Z Huang*, SG Kang*, Y Li*, J Zak, N Shaabani, K Deng, J Shepherd, ...
Science Advances 7 (13), eabb8087, 2021
102021
Ruxolitinib Plus Nivolumab in Patients with R/R Hodgkin Lymphoma after Failure of Check-Point Inhibitors: Preliminary Report on Safety and Efficacy
V Bachanova, L Hegerova, Q Cao, M Janakiram, J Maakaron, ...
Blood 138 (Supplement 1), 230-230, 2021
92021
ASPP2 deficiency causes features of 1q41q42 microdeletion syndrome
J Zak, V Vives, D Szumska, A Vernet, JE Schneider, P Miller, EA Slee, ...
Cell Death & Differentiation 23 (12), 1973-1984, 2016
82016
Aspp1: A Guardian of Hematopoietic Stem Cell Integrity
J Zak, X Lu
Cell Stem Cell 17 (1), 3-5, 2015
62015
Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases
AT Pagnamenta, C Camps, E Giacopuzzi, JM Taylor, M Hashim, ...
Genome Medicine 15 (1), 94, 2023
32023
ISG15 drives immune pathology and respiratory failure during viral infection
N Shaabani, J Zak, JL Johnson, Z Huang, N Nguyen, DC Lazar, ...
bioRxiv, 2020.04. 13.039321, 2020
32020
GOLD and phenotypes: The new Czech COPD guidelines
V Koblizek, J Chlumsky, V Zindr, J Kocianova, J Zatloukal, ...
European Respiratory Journal 46 (suppl 59), PA3937, 2015
32015
Phase 1 trial of Ruxolitinib combined with Nivolumab in patients relapsed/refractory Hodgkin lymphoma after failure of check‐point inhibitor (CPI)
V Bachanova, J Zak, Q Cao, J Maakaron, B Grzywacz, C Fletcher, ...
Hematological Oncology 41, 582-582, 2023
22023
Enhancing the anti-tumor efficacy of Bispecific T cell engagers via cell surface glycocalyx editing
Z Yang, Y Hou, G Grande, C Wang, Y Shi, J Zak, JH Cho, ...
bioRxiv 492978, 2023
22023
The system can't perform the operation now. Try again later.
Articles 1–20